A Modern Approach to the Treatment of Cancer and Other Serious Diseases

RFE modulated control of charge pathways has the potential to significantly
change the way cancer and other serious diseases are treated.

See Our Science

Nativis is a clinical stage bioelectronics company developing non-invasive therapies for cancers and other serious diseases. At the interface of chemistry and physics, our proprietary Radio Frequency Energy (RFE) technology regulates defined bioactive targets by specific modulation of charge pathways. RFE modulated control of charge pathways has the potential to significantly change the way cancer and other serious diseases are treated.

More About Us

Scientific Platform

Nativis science and technology is based on magnetically induced electron and charge transfer. Electron transfer is central to the function of many biologic processes and artificial magnetic fields are capable of triggering a receptor response and conformational change in the absence of a physical agonist. A specific and precise oscillating magnetic field with the proper vector, magnitude and pulse duration can move a charge along a protein pathway much the same way an electron is forced to move in copper wire.

A charge moving between a donor and acceptor site in the presence of an oscillating magnetic field will result in a conformational dynamic similar to a naturally forced charge.” [Annu. Rev. Biophys. Chem. 1990, 19. &lquo;267-99]

See Our Science